The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 2
- 2 new
- Median first-year cost
- $211,084
- $422,168 in all
- Institutions
- 2
- 2 contact PIs
Awards by fiscal year
0
2
0
0
0
0
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- BOSTON UNIVERSITY MEDICAL CAMPUS1
- UNIVERSITY OF ILLINOIS AT CHICAGO1
Most frequent study sections
- Special Emphasis Panel (ZCA1 GRB-S (J1))2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2015 | IGPR-1 in colon cancer chemotherapy1R21CA193958-01 | Rahimi, Nader | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | First-year cost $213,629 | Study section ZCA1 |
| FY2015 | Cytoplasmic FOXM1 contributes to the higher complete remission and longer overall survival of AML patients after chemotherapy1R21CA194608-01 | Gartel, Andrei L | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | First-year cost $208,539 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-21-0.3.10. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.